Guidance Capital’s Boston Scientific BSX Stock Holding History

Guidance Capital’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$513K	Buy	11,573 +5,243	+83%	+$243K	0.11%	167
2026 Q2	$282K	Buy	+6,330	New	+$344K	0.06%	211
2026 Q1	–	Sell	-4,699	Closed	-$429K	–	237
2025 Q4	$429K	Buy	4,699 +5	+0.1%	+$490	0.1%	169
2025 Q3	$475K	Sell	4,694 -1,100	-19%	-$114K	0.12%	160
2025 Q2	$611K	Buy	5,794 +2,015	+53%	+$204K	0.17%	123
2025 Q1	$397K	Buy	+3,779	New	+$381K	0.12%	155

Other funds holding BSX

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return

Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

Guidance Capital's BSX Position: Q3 2026 in Review

Guidance Capital increased its Boston Scientific (BSX) stake by 83% in Q3 2026, buying an estimated $243K and bringing the position to 11,573 shares worth $513K. The position accounts for 0.11% of the portfolio, ranked #167.

Guidance Capital first reported a position in BSX in Q1 2025 and has held it in 6 quarters since. The position peaked at $611K in Q2 2025. 1,116 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

Guidance Capital held 11,573 shares of Boston Scientific worth $513K as of Q3 2026.
Guidance Capital bought 5,243 Boston Scientific shares in Q3 2026, an estimated $243K.
Boston Scientific made up 0.11% of Guidance Capital's portfolio in Q3 2026, its #167 holding.
Guidance Capital first reported a position in Boston Scientific in Q1 2025 and has held it in 6 quarters since.
Guidance Capital's Boston Scientific position peaked at $611K in Q2 2025.
1,116 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Guidance Capital's 13F filing for Q3 2026, filed 3 Nov 2026.